INVO Bioscience, Inc.
INVO
$2.00
$0.179.29%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.25M | -1.60M | -1.99M | -1.25M | -2.24M |
| Total Depreciation and Amortization | 230.30K | 227.00K | 141.60K | 20.50K | 19.70K |
| Total Amortization of Deferred Charges | 251.00K | 98.00K | 107.90K | 311.20K | 122.70K |
| Total Other Non-Cash Items | 1.12M | 725.90K | 505.80K | 318.60K | 467.50K |
| Change in Net Operating Assets | -809.50K | 285.10K | 524.70K | -649.20K | -13.80K |
| Cash from Operations | -1.46M | -260.60K | -714.90K | -1.25M | -1.64M |
| Capital Expenditure | -55.10K | -49.70K | -75.00K | -108.20K | -261.50K |
| Sale of Property, Plant, and Equipment | 50.00K | 25.60K | -- | -- | -- |
| Cash Acquisitions | -- | -- | 108.30K | -2.15M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -5.10K | -24.10K | 33.30K | -2.26M | -261.50K |
| Total Debt Issued | 217.50K | 225.00K | 0.00 | 2.45M | 0.00 |
| Total Debt Repaid | -361.00K | -197.60K | -141.50K | -993.70K | -190.20K |
| Issuance of Common Stock | 1.07M | -- | -- | 3.00M | 20.30K |
| Repurchase of Common Stock | -- | -- | 0.00 | -- | -- |
| Issuance of Preferred Stock | 1.01M | 500.00K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.93M | 527.40K | -141.50K | 4.45M | -169.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 467.80K | 242.70K | -823.10K | 943.10K | -2.08M |
